0000895813-21-000015.txt : 20211117
0000895813-21-000015.hdr.sgml : 20211117
20211117094610
ACCESSION NUMBER: 0000895813-21-000015
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201215
FILED AS OF DATE: 20211117
DATE AS OF CHANGE: 20211117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hopper Paul
CENTRAL INDEX KEY: 0001355220
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39788
FILM NUMBER: 211418732
MAIL ADDRESS:
STREET 1: 7982 DOUG HILL
CITY: SAN DIEGO
STATE: CA
ZIP: 92127
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Scopus BioPharma Inc.
CENTRAL INDEX KEY: 0001772028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821248020
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 LEXINGTON AVENUE, SUITE 300
CITY: NEW YORK
STATE: NY
ZIP: 10170
BUSINESS PHONE: (212) 479-2513
MAIL ADDRESS:
STREET 1: 420 LEXINGTON AVENUE, SUITE 300
CITY: NEW YORK
STATE: NY
ZIP: 10170
FORMER COMPANY:
FORMER CONFORMED NAME: Scopus Biopharma Inc.
DATE OF NAME CHANGE: 20190327
3
1
ownership.xml
X0206
3
2020-12-15
0
0001772028
Scopus BioPharma Inc.
SCPS
0001355220
Hopper Paul
101/50 MCLACHLAN AVENUE
RUSHCUTTERS BAY
C3
2011
AUSTRALIA
1
0
0
0
Common Stock
700000
I
By Moreglade Pty. Limited
Common Stock
6333
D
W Warrant
2021-10-01
2026-09-30
B Unit
503636
I
By Moreglade Pty. Limited
W Warrant
2021-10-01
2026-09-30
B Unit
4557
D
Mr. Hopper is a director of Moreglade Pty. Limited and therefore is deemed to have shared voting and dispositive power over the shares of Common Stock and W Warrants held by this entity. Mr. Hopper disclaims beneficial ownership of the shares of Common Stock and W Warrants held by this entity, as he has no pecuniary interest therein.
Excludes 6,333 shares owned by Mr. Hopper's spouse and an aggregate of 50,668 shares owned by Mr. Hopper's adult children, as to which shares he disclaims beneficial ownership.
Each W Warrant is exercisable for one B Unit. Starting on April 1, 2022, each B Unit can be separated into one share of common stock and one Z Warrant. Each Z Warrant is exercisable for one share of common stock with an exercise price of $5.00 per share. The Z Warrant will become exercisable on July 1, 2022 and will expire on June 30, 2027.
Excludes 4,557 W Warrants owned by Mr. Hopper's spouse and an aggregate of 36,452 W Warrants owned by Mr. Hopper's adult children, as to which warrants he disclaims beneficial ownership.
/s/ Paul Hopper
2021-11-17